NNL-Istituto Nanoscienze, CNR, Lecce, Italy.
Curr Pharm Des. 2012;18(27):4155-64. doi: 10.2174/138161212802430404.
In this review we will report on recent advanced in polyelectrolyte capsules for targeted drug delivery (eg of growth factor inhibitor) against epatocarcinoma. Degradable polyelectrolyte multilayers capsules (PMCs) are of particular interest for cancer therapy since under physiological conditions they can be enzymatically degraded upon cell interaction. Small bioactive molecules such as TGF-Beta inhibitors can be incorporated inside them. Nano-to-microscale delivery systems can enhance efficacy at single cell level for targeted therapy. Layer-by-layer (LbL) self-assembled capsules are novel carriers maximizing drug administration and improving antimetastatic activity of TGF-Beta inhibitors in Hepatocellular Carcinoma (HCC).
在这篇综述中,我们将报告最近在用于针对肝癌的靶向药物递送(例如生长因子抑制剂)的聚电解质胶囊方面的进展。可降解的聚电解质多层胶囊(PMCs)特别适用于癌症治疗,因为在生理条件下,它们可以在与细胞相互作用时被酶降解。小的生物活性分子,如 TGF-β抑制剂,可以被包含在其中。纳米到微米级的递药系统可以提高靶向治疗的单细胞水平的疗效。层层自组装胶囊是新型载体,可最大限度地提高药物的给药量,并提高 TGF-β抑制剂在肝细胞癌(HCC)中的抗转移活性。